Teaching patients how to look their best. Please join us for our next meeting.
Click here for FAQs and other useful information on all types of cancer and treatment options.
A Phase II Trial of Panitumumab, Gemcitabine, and Carboplatin in Triple-Negative Metastatic Breast Cancer (Sarah Cannon Research Institute BRE 126)
Phase II Study of Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER2-Negative Breast Cancer (Sarah Cannon Research Institute BRE 133)
A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxel as First-Line Treatment for ErbB-2 Positive Locally Recurrent or Metastatic Breast Ca
A Multicenter, Multinational, Randomized, Double-Blind, Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients with HER2-Negative, Unresectable, Loc
A Randomized Trial of Ixempra ™ vs. Taxol in Adjuvant Therapy of Triple Negative Breast Cancer (Sarah Cannon Research Institute BRE 145).
By Dr. Aleksandar Jankov
I was about to slide my hand into the sterile glove when my patient, George, interrupted the quiet business of the procedure room.